Norvir Related Clinical Trials
Bioequivalence Study of Generic GPO Ritonavir Versus Norvir® [Completed]
Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART [Completed]
Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir® [Not yet recruiting]
TMC310911-TiDP21-C201 - A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-naive HIV-1-infected Patients [Recruiting]
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects [Recruiting]
Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects [Active, not recruiting]
Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor [Completed]
Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Recruiting]
Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin [Not yet recruiting]
Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV [Active, not recruiting]
Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Na�ve HIV-1 Infected Subjects. [Recruiting]
Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens [Recruiting]
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer [Recruiting]
Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. [Recruiting]
Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women [Recruiting]
Genetic Predictors of Variability in the Drug-Drug Interaction Between Darunavir/Ritonavir and Pravastatin [Recruiting]
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure [Active, not recruiting]
Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily [Recruiting]
Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children [Recruiting]
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [Completed]
A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women [Recruiting]
Drug Interactions Between Atazanavir Plus Ritonavir Coadministered With Voriconazole in Healthy Subjects [Recruiting]
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients [Completed]
KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18) [Recruiting]
Drug Interaction Study With Proton Pump Inhibitor [Completed]
NNRTI/PI Toxicity Switch to Darunavir Study [Recruiting]
Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women [Recruiting]
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression [Recruiting]
Investigation of Ritonavir Effects on Afatinib Exposure in Healthy Subjects [Recruiting]
Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients [Completed]
Atazanavir/Ritonavir (ATV/RTV) Once a Day (QD) + Raltegravir (RAL) Twice a Day (BID) Stable Switch Study [Recruiting]
A Relative Bioavailability Study of Danoprevir and Ritonavir in Healthy Volunteers [Not yet recruiting]
A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers [Recruiting]
"The Once A Day Protease Inhibitor Regimens" [Active, not recruiting]
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects [Completed]
A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects [Active, not recruiting]
Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir [Completed]
Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir [Recruiting]
A Study of Danoprevir/Ritonavir and Copegus With RO5024048 and/or Pegasys in Patients With Chronic Hepatitis C [Recruiting]
Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children [Recruiting]
Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Completed]
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection [Recruiting]
The Effect of Atazanavir and Ritonavir on the Pharmacokinetics of Oral Norethindrone [Recruiting]
Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [Completed]
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma [Not yet recruiting]
A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients [Completed]
Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-Infected Patients [Recruiting]
A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers [Recruiting]
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 [Recruiting]
Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil [Active, not recruiting]
Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults [Recruiting]
The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients [Completed]
A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis [Not yet recruiting]
Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone [Completed]
GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir [Recruiting]
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]
Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours [Recruiting]
A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls [Recruiting]
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases [Recruiting]
A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules [Not yet recruiting]
Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females [Completed]
GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection [Active, not recruiting]
BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes [Recruiting]
Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral NaÑ—ve Patients [Completed]
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [Active, not recruiting]
Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment [Active, not recruiting]
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL) [Recruiting]
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir [Completed]
ATV/Ritonavir Nevirapine Interaction (USPAC) [Completed]
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada [Active, not recruiting]
Pharmacokinetics of Low Dose Ritonavir [Recruiting]
Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects [Completed]
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue [Not yet recruiting]
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children [Active, not recruiting]
Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2) [Active, not recruiting]
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men. [Active, not recruiting]
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients [Completed]
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Recruiting]
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects [Active, not recruiting]
Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF) [Recruiting]
Ritonavir-Boosted GS-9137 Vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART. [Active, not recruiting]
Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors [Completed]
Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment [Active, not recruiting]
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia [Completed]
Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment [Active, not recruiting]
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma [Completed]
Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance [Completed]
The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir [Completed]
The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment [Active, not recruiting]
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment [Active, not recruiting]
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors [Completed]
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs [Active, not recruiting]
ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past [Completed]
Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies [Completed]
Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs [Active, not recruiting]
Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants [Active, not recruiting]
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [Active, not recruiting]
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR [Completed]
Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir [Completed]
TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age [Not yet recruiting]
|
